Results 211 to 220 of about 44,745 (266)

Competing Colloidal Interactions Govern Polymer Encapsulation of Hydrophobic Iron Oxide Nanoparticles. [PDF]

Langmuir
Biswas S, Sindhu TA, Haider MS, Mani E, Bandyopadhyay S.   +4 more
europepmc   +1 more source

EGFR-Targeted Nanoparticle Delivery of Osimertinib for Triple-Negative and Metastatic Breast Cancer Therapy. [PDF]

Pharmaceutics
Alfagih IM, Alfagih M, Almurshedi A, Aldosari B, Alquadeib B, Hajjar B, Almogheerah S, Alzahrani R.   +7 more
europepmc   +1 more source

Development and Characterization of a Structurally Supportive of Hybrid PLGA Decellularized ECM Biomembrane for Ocular Progenitor Cell Anchorage and Epithelial Repair. [PDF]

Macromol Biosci
Ungaratti AKG, de Lima AP, Santos JA, de Melo PL, Graziani D, da Silva ACG, Silva LAD, Valadares MC.   +7 more
europepmc   +1 more source

Combination of Polymeric Microneedles with Specific Peptide for TNF‑α Sensing Via Noninvasive Detection in Interstitial Fluid. [PDF]

ACS Omega
Palma A, Di Natale C, Tammaro D, Lagreca E, Cugudda A, La Manna S, Ferraro V, Vespini V, Grilli S, Maffettone PL, Coppola S.   +10 more
europepmc   +1 more source

Electrospun Chitosan/Collagen Fibers Incorporating PLGA and Hydroxyapatite Nanoparticles for In-Vitro 3T3 Fibroblast Migration. [PDF]

Polymers (Basel)
Procel-Badillo L, Briceño S, Ramírez L, González G.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet Compatibility of PLGA, Chitosan and PLGA–Chitosan Nanoparticles

Nanomedicine, 2009
The increasing interest in biodegradable nanoparticles containing biomaterials such as poly(D,L-lactide-co-glycolide) (PLGA) and chitosan for drug delivery raises issues regarding the blood compatibility of these nanoparticles, since some nanoparticles, including carbon nanoparticles, can affect human platelet aggregation and cause vascular thrombosis.
Xue, Li, Anna, Radomski, Owen I, Corrigan, Lidia, Tajber, Fabio, De Sousa Menezes, Sibylle, Endter, Carlos, Medina, Marek W, Radomski   +7 more
openaire   +2 more sources

Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomonas

International Journal of Pharmaceutics, 2008
The aim of present study was to examine whether cationic Eudragit containing poly(lactide-co-glycolide) (PLGA) nanoparticles can adhere to Pseudomonas aeruginosa and Staphylococcus aureus. In order to prepare fluorescent nanoparticles, fluorescein was covalently coupled to PLGA.
Dillen, Kathleen, Bridts, Chris, van der Veken, Pieter, Cos, Paul, Vandervoort, Jo, Augustyns, Koen, Stevens, Wim, Ludwig, Annick   +7 more
openaire   +3 more sources

Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles

International Journal of Pharmaceutics, 2001
The effect of nanoparticle dose on the biodistribution and pharmacokinetics of conventional PLGA and stealth poly(Lactide-co-glycolide)-monomethoxypoly(ethyleneglycol) (PLGA-mPEG) nanoparticles was investigated. The precipitation-solvent diffusion method was used to prepare PLGA and PLGA-mPEG nanoparticles labeled with 125I-cholesterylaniline.
Z, Panagi, A, Beletsi, G, Evangelatos, E, Livaniou, D S, Ithakissios, K, Avgoustakis   +5 more
openaire   +2 more sources